|
Market Closed -
Nasdaq
16:00:00 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 0.7640 USD | +0.28% |
|
-1.42% | -67.07% |
Evolution of the Average Target: Dermata Therapeutics, Inc.
Evolution of the Target Price: Dermata Therapeutics, Inc.
Changes in Analyst Recommendations: Dermata Therapeutics, Inc.
3.wFqN6f46G4htbQ7T62Q3fLjyriad5en61ykfT770pWQ.iTHYoKZ-Ks8aBFugmA5VGouGnXCr17DIsHBoDJOO8FO5beDRoVBX8lg9Vw~ccc3c8950e596947b3575d0005f70738
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +423.56% | |||
| +37.65% | |||||
| +7.56% | |||||
| +23.18% | |||||
| +7.52% | |||||
| +14.74% | |||||
| +35.98% | |||||
| +29.79% | |||||
| +13.61% | |||||
| +26.56% | |||||
| Average | +62.01% | |||||
| Weighted average by Cap. | +21.94% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.7640USD
Average target price
4.000USD
Spread / Average Target
+423.56%
High Price Target
4.000USD
Spread / Highest target
+423.56%
Low Price Target
4.000USD
Spread / Lowest Target
+423.56%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- DRMA Stock
- Consensus Dermata Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
